Journal profile · ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Cancer Imaging
ISSN 1470-7330 · BioMed Central · ENGLAND · Founded 2000
Cancer Imaging: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.77; fully open access; APC about USD 2,890; median 119 days to acceptance (101 articles, last 24 months); community-reported acceptance: fairly easy; 159 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cancer Imaging is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Radiomics and Machine Learning in Medical Imaging, MRI in cancer diagnosis and Medical Imaging Techniques and Applications, together about 36.4% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
As the official journal of the International Cancer Imaging Society, and written by renowned international experts in the field, Cancer Imaging encompasses the interdisciplinary and innovative field of cancer imaging, publishing the latest original research, reviews, correspondence, and editorials. The journal’s open access format provides a highly visible forum to radiologists, nuclear medicine specialists, oncologists, ontological surgeons, and those interested in the field. Editor-in-Chief Prof. Khaled Elsayes MD View all editors
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Editor-in-chief Khaled ElsayesPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named United States 26, Germany 7, Italy 5, Canada 4, United Kingdom 3 (65 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Radiomics and Machine Learning in Medical ImagingMedicine17.1%
- MRI in cancer diagnosisMedicine10.3%
- Medical Imaging Techniques and ApplicationsMedicine9.1%
- Lung Cancer Diagnosis and TreatmentMedicine7.2%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine7.1%
- Prostate Cancer Diagnosis and TreatmentMedicine3.3%
- Head and Neck Cancer StudiesMedicine3.3%
- Glioma Diagnosis and TreatmentMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.77LetPub ·
- Impact factor (publisher) 2025
- 4.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.8Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 1.16LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 40LetPub ·
- h-index
- 84OpenAlex ·
- i10-index
- 978OpenAlex ·
- 2-year mean citedness
- 5.28OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 156LetPub ·
- Downloads per year (publisher) 2025
- 1,300,000Publisher website ·
Articles by year OpenAlex count · 2,120 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 151 | 151 | 39 |
| 2025 | 159 | 159 | 632 |
| 2024 | 173 | 173 | 1,881 |
| 2023 | 128 | 128 | 1,676 |
| 2022 | 78 | 78 | 1,292 |
| 2021 | 68 | 68 | 1,544 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
119 daysMedian, submission to acceptance · P25–P75 74 days – 181 days
- Acceptance to online
- median 11 days (101 articles)
- Submission to online
- median 132 days
- Sample
- 101 articles with submission and acceptance dates (356 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to publication (journal-reported)
- about 9 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,490 / USD 2,890 / GBP 2,290 | Yes | CC BY, CC0 | |
| OpenAlex | USD 2,790 / EUR 2,390 / GBP 2,190 | — | — | |
| LetPub | GBP 2,090 / USD 2,690 / EUR 2,290 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2000
- ISSN
- 1470-7330
- Society / sponsor
- International Cancer Imaging Society
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Imaging
What CAS zone is Cancer Imaging in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Imaging is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Imaging?
The latest impact factor listed by LetPub is 4.77; CiteScore 5.9, h-index 84.
How long does peer review take at Cancer Imaging?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 74–181 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cancer Imaging based?
Of the 65 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are United States (26), Germany (7) and Italy (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer Imaging?
According to LetPub and DOAJ records, Cancer Imaging is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Cancer Imaging open access, and what is the APC?
Cancer Imaging is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .